Fluticasone News
Sepracor Gains New Line but Faces CMS Troubles
Sepracor Inc. had good and bad news for shareholders this week. In what the Marlborough, Mass.-based firm viewed as positive news, it acquired the U.S. development, marketing and commercialization rights to Nycomed's...
Nycomed finds a US partner for asthma drug
The decision by Sepracor to in-license the US marketing rights to inhaled corticosteroid Alvesco caps a four-year commercial and regulatory odyssey for the asthma drug.
Fostair(R) Launched In The UK For The Regular Treatment Of Adults With Asthma
Fostair, the first and only metered-dose inhaler combining belcometasone dipropionate (inhaled corticosteroid, ICS) and formoterol fumarate dihydrate (long-acting beta2 agonist, LABA) is launched in the UK for the regular...
Hi-Tech Gets FDA OK for Generic Flonase
Hi-Tech Pharmacal Co. Inc. said Wednesday the Food and Drug Administration granted final approval to the drug maker's generic version of GlaxoSmithKline PLC's nasal spray Flonase for the management of nasal allergy symptoms.
Allergic Rhinitis Treatment Avamys (fluticasone furoate) Approved in Europe
GlaxoSmithKline plc today announced that once-daily Avamys™(fluticasone furoate) nasal spray has been granted marketing authorisation by the European Commission for all 27 European member states, for the treatment of the symptoms...